Jump to content

Search the hub

Showing results for tags 'Blood / blood products'.


More search options

  • Search By Tags

    Start to type the tag you want to use, then select from the list.

  • Search By Author

Content Type


Forums

  • All
    • Commissioning, service provision and innovation in health and care
    • Coronavirus (COVID-19)
    • Culture
    • Improving patient safety
    • Investigations, risk management and legal issues
    • Leadership for patient safety
    • Organisations linked to patient safety (UK and beyond)
    • Patient engagement
    • Patient safety in health and care
    • Patient Safety Learning
    • Professionalising patient safety
    • Research, data and insight
    • Miscellaneous

Categories

  • Commissioning, service provision and innovation in health and care
    • Commissioning and funding patient safety
    • Digital health and care service provision
    • Health records and plans
    • Innovation programmes in health and care
    • Climate change/sustainability
  • Coronavirus (COVID-19)
    • Blogs
    • Data, research and statistics
    • Frontline insights during the pandemic
    • Good practice and useful resources
    • Guidance
    • Mental health
    • Exit strategies
    • Patient recovery
    • Questions around Government governance
  • Culture
    • Bullying and fear
    • Good practice
    • Occupational health and safety
    • Safety culture programmes
    • Second victim
    • Speak Up Guardians
    • Staff safety
    • Whistle blowing
  • Improving patient safety
    • Clinical governance and audits
    • Design for safety
    • Disasters averted/near misses
    • Equipment and facilities
    • Error traps
    • Health inequalities
    • Human factors (improving human performance in care delivery)
    • Improving systems of care
    • Implementation of improvements
    • International development and humanitarian
    • Safety stories
    • Stories from the front line
    • Workforce and resources
  • Investigations, risk management and legal issues
    • Investigations and complaints
    • Risk management and legal issues
  • Leadership for patient safety
    • Business case for patient safety
    • Boards
    • Clinical leadership
    • Exec teams
    • Inquiries
    • International reports
    • National/Governmental
    • Patient Safety Commissioner
    • Quality and safety reports
    • Techniques
    • Other
  • Organisations linked to patient safety (UK and beyond)
    • Government and ALB direction and guidance
    • International patient safety
    • Regulators and their regulations
  • Patient engagement
    • Consent and privacy
    • Harmed care patient pathways/post-incident pathways
    • How to engage for patient safety
    • Keeping patients safe
    • Patient-centred care
    • Patient Safety Partners
    • Patient stories
  • Patient safety in health and care
    • Care settings
    • Conditions
    • Diagnosis
    • High risk areas
    • Learning disabilities
    • Medication
    • Mental health
    • Men's health
    • Patient management
    • Social care
    • Transitions of care
    • Women's health
  • Patient Safety Learning
    • Patient Safety Learning campaigns
    • Patient Safety Learning documents
    • Patient Safety Standards
    • 2-minute Tuesdays
    • Patient Safety Learning Annual Conference 2019
    • Patient Safety Learning Annual Conference 2018
    • Patient Safety Learning Awards 2019
    • Patient Safety Learning Interviews
    • Patient Safety Learning webinars
  • Professionalising patient safety
    • Accreditation for patient safety
    • Competency framework
    • Medical students
    • Patient safety standards
    • Training & education
  • Research, data and insight
    • Data and insight
    • Research
  • Miscellaneous

News

  • News

Find results in...

Find results that contain...


Date Created

  • Start
    End

Last updated

  • Start
    End

Filter by number of...

Joined

  • Start

    End


Group


First name


Last name


Country


Join a private group (if appropriate)


About me


Organisation


Role

Found 137 results
  1. Content Article
    This article in The Lancet Haematology examines the impact of having different anaemia thresholds for men and for women at different life stages. It challenges the data that current medical assumptions are based on, arguing that they have been extrapolated from healthy, predominantly white populations that are not representative of real-world populations. The authors look at the arguments that has been used to determine sex-based differences in haemoglobin concentrations, and argue that there is limited evidence to justify having different anaemia thresholds for men and women. They suggest that removing sex-specific reference ranges for haemoglobin and ferritin may improve the health of women and their offspring.
  2. Content Article
    Professor Ahmet Fuat, North East and North Cumbria Cardiac Network Heart Failure Lead, shares how one tool is helping reduce the current pressures and deliver better outcomes for patients. NT-proBNP testing – a NICE recommended diagnostic tool – is being used to rule out heart failure in primary care. In the North East and North Cumbria, patients must have an NT-proBNP test to be referred for an echocardiogram. This mandated testing helps them to streamline the diagnosis journey for heart failure patients by confirming or ruling out heart failure at the earliest possible opportunity, and reducing unnecessary referrals for echos. For patients, this saves time and distress, and for GPs and Nurse Practitioners, which reduces the number of repeat visits these patients often need to make.
  3. News Article
    NHS stocks of blood may become “critical” this winter, a regulator has warned, as Covid and higher than average winter rates of cold and flu risk donation levels. The NHS Blood and Transplant authority declared a major incident at the end of October after its supply of blood supplies dropped to critical levels, nationally. The regulator’s supply was at risk of dropping to below two days’ supply across the country, when it aims to have at least five days at all times. This is the second time the regulator, which is responsible for blood donation supplies to the NHS, has declared a critical incident in the last 12 months. The last time the regulator declared an incident over low stocks was due to bad weather and snow in 2018 during the “beast from the east” storm and in Cornwall in 2019, which resulted in decreased donation levels. Read full story Source: The Independent, 12 December 2021
  4. News Article
    Lung transplant patients in Birmingham are facing significantly worse survival rates as a “sobering” report has revealed two-thirds of patients have died within five years, The Independent has learned. Survival rates for lung transplant patients at University Hospitals Birmingham Foundation Trust after five years are now almost 20 percentage points lower than the other main hospitals specialising in lung transplants. The latest figures from NHS Blood and Transplant (NHSBT) have revealed Birmingham’s five-year survival rates decreased from 79% in 2015-16 to 31% in 2020-21, and have consistently been the lowest compared to the other four other transplant hospitals in Newscastle, Cambridgeshire, London and Manchester. The latest NHSBT’s report showed of those patients who had a transplant in Birmingham between 2012 to 2016, 31 per cent survived. During the same period in Newcastle 47 per cent of patients survived, in Papworth and Manchester 51%, while London’s Royal Harefield recorded a 56 per cent survival rate. Birmingham recorded the lowest patient survival rates 90 days after surgery and for one year after surgery between 2016-17 to 2020-21. Although for these measures the hospital was within the national average, unlike its five-year survival rates. One transplant surgeon has raised concerns over the continued poor survival rates at Birmingham, claiming they showed the “staggering” failure for the programme in the city to improve. Read full story Source: The Independent, 23 November 2021
  5. News Article
    From the end of 2021, a question on sexual activity of partners in areas where HIV is widespread will be removed from the donor safety check form, in an effort to increase inclusivity among donors. The changes will particularly improve the ease to donate blood for Black African donors. Currently, prospective donors are asked if they have recently had sex with a partner who may ever have been sexually active in an area where HIV is endemic, which includes most of sub-Saharan Africa. If they have, the donor will then be deferred for three months after the last sexual contact with that partner. This can often mean Black African and other potential donors in long-term relationships have been unable to donate blood. Now, the UK Government has outlined plans to remove the question from those asked in the donor safety check, opening the door to a greater number of donations. Increasing blood donor inclusivity for those who are Black African, Black Caribbean, and of Black mixed ethnicity is particularly important because they are more likely to have the rare blood sub-group, such as Ro, that many Black sickle cell patients need. The change, making it easier for people from these groups to donate, will create greater opportunities to meet the ongoing need for rarer blood types and help improve and save lives in the UK. Read full story Source: National Health Executive, 11 October 2021
  6. Content Article
    Serious Hazards of Transfusion (SHOT) introduced a new Human Factors Investigation Tool (HFIT) in 2021. The tool can be used to investigate and capture systemic as well as individual factors where there has been an error. This case study uses the updated Human Factors Investigation Tool and Systems Engineering Initiative for Patient Safety (SEIPS) framework to work through an ABO incompatible red cell transfusion case reported to SHOT.
  7. News Article
    It was "regrettable" that the government said there was "no conclusive proof" AIDS could be transmitted by blood products in 1983, a public inquiry has heard. Giving evidence, former secretary of state Lord Fowler said it would have been better to add that it was likely NHS treatment could be contaminated. But he said he didn't think the change would have made a crucial difference. Survivors have accused ministers of playing down the risks at the time. It's thought around 3,000 haemophiliacs died of AIDS and hepatitis C after being treated with a blood-clotting product called Factor VIII in the 1970s and 1980s. Groups representing families of those affected by the scandal claim the use of the phase "no conclusive proof" minimised the danger from blood products at the time. Read full story Source: BBC News, 22 September 2021
  8. News Article
    GP surgery staff are facing abuse from patients who are “angry and upset” that their blood test has been cancelled because of the NHS-wide chronic shortage of sample bottles. “Patients are angry when we ring them up and say, ‘Sorry we can’t do your blood test after all’. A lot of people are quite angry and concerned about their own health,” Dr David Wrigley, the deputy chair of council at the British Medical Association, said. “Patients are quite rightly upset and some get quite aggressive as well. They are worried because they don’t know what the implications of their cancelled test are for their health.” GP practices in England had begun cancelling appointments because the NHS’s main supplier could not deliver stocks as planned for one to two weeks because of “unforeseen road freight challenges”. NHS England has responded to the shortage of blood sample bottles by telling GPs to cancel all but clinically urgent blood tests and hospitals to cut back the tests they do by at least 25%. Read full story Source: The Guardian, 6 September 2021
  9. News Article
    Becton Dickinson (BD), which manufactures most of the blood tubes used by the NHS, has alerted NHS England and NHS Improvement (NHSE/I) to a global shortage of some of its products, including two types of blood tubes: those with a yellow or purple top. BD says that the COVID-19 pandemic created the most unpredictable demand it has seen in the past 70 years. The company says that it has also been difficult for customers to predict the types and quantities of blood tubes they will be using from month to month, which affects manufacturers’ abilities to meet demand. “Adding to the issue are global transportation delays that have resulted in more products being tied up in transportation than is normal, creating additional delays in deliveries,” BD said in a statement. “Raw material suppliers are also challenged to keep up with demand for materials and components.” In the UK, BD has been authorised to import blood tubes that are approved for use in other regions of the world, including the United States. It plans to deliver nine million of these additional blood tubes to the NHS for immediate distribution. Read full story (paywalled) Source: BMJ, 3 September 2021
  10. News Article
    Doctors have warned GPs are having to make difficult choices about which patients get blood tests because of the ongoing shortage of test tubes, describing it as a "perilous" situation. Due to the shortages, the NHS in England and Wales have told surgeries and hospitals to temporarily stop some blood testing, which includes tests for fertility, allergies and pre-diabetes. One woman, Alison Webb, has said she cannot have her yearly thyroid and cholesterol checked due to the shortages - and her tests are already overdue by four months. A Department of Health and Social Care spokesperson said, "The health and care system continues to work flat out with the supplier and stakeholders to put mitigations in place, and restore normal supply, and there continues to be stock in place." Read full story. Source: BBC News, 30 August 2021
  11. News Article
    Local NHS organisations are increasing their efforts to conserve ubiquitous blood collection products amid concerns current measures are not working and stocks may run even lower. There is also a concern in east London that the message to reduce routine tests is not being heeded, with GPs not cutting back enough. However, this week the British Medical Association raised concerns over suspending routine tests, including “NHS Health Checks, monitoring of quality of care, and medication reviews”. The union said: “It would also be unreasonable to ask healthcare staff to simply delay these tests until a later date — not only for the sake of our patients, but also the entire system, which is already tackling an enormous backlog of care.” Read full story. Source: HSJ, 25 August 2021
  12. News Article
    On 10 August NHS England issued guidance for healthcare workers, including medical directors and GPs, in the light of global shortages of blood tube products, now, doctors have raised concerns about the effects that a shortage of blood tubes in England will have on patient care and the NHS, which already faces backlogs. Read full story (paywalled). Source: BMJ, 24 August 2021
  13. News Article
    Plasma from blood donations in England will be used to make a life-saving drug whilst also helping to secure NHS plasma stocks to make the antibody-based medicines, called immunoglobulins. The service will begin roll-out in the coming months, with other parts of the UK potentially following suit. Gerry Gogarty, from NHS Blood and Transplant, welcomed the decision, calling it a huge step forward. "By recovering plasma from blood donations, we can improve long-term supplies of immunoglobulin medicine, and each generous blood donation will go even further in helping to save the lives." Read full story. Source: BBC News, 17 August 2021
  14. News Article
    According to reports, Barts Health Trust and most other providers in the north east London health system may run out of blood tube collection products by the end of August. Though, according to notes seen by HSJ, a “mitigation plan with demand management in place this may extend into September”. After warning colleagues in north east London that the shortage of blood collection tubes made by Becton Dickinson affects “all NEL areas” except acute trust Barking, Havering and Redbridge University Hospitals Trust, Diane Jones, chief nurse of the NEL integrated care system has said “NHSE are looking at mitigations, but nothing confirmed as yet, and [they] may take a few weeks to come on stream. The mitigation may get us up to 50 per cent of usual supply in the short term.” Read full story (paywalled). Source: HSJ, 13 August 2021
  15. Content Article
    The efficacy of injection therapy in diabetes depends on correct injection technique. The aim of the Insulin Injection Technique Questionnaire was to understand how people with diabetes inject, so that guidance can be tailored towards improving injection technique. This article in the Journal of Diabetes analyses the results of the 2008-2009 survey and identifies areas where improvements have been made since the last survey, and areas where there is still progress to be made.
  16. News Article
    According to NHSE guidance today, non-essential blood tests should be stopped and GPs should prioritise genomic tests over others. Vitamin D testing should also be stopped in all, but "exceptional circumstances" amid shortages in the blood collection tube stocks. The guidance, issued by the NHSE has advised genomics for testing of unwell neonates, prenatal screening and cancer diagnoses are “a high priority". NHSE have also said changes to testing “should be made in consultation with individual patients” and that “it is important to make clear that routine tests will be deferred only where it is clinically safe to do so”. Read full story (paywalled). Source: HSJ, 10 August 2021
  17. News Article
    A national shortage in blood collection tubes has meant trusts are having to limit blood tests, with some trusts advising doctors to only order blood tests if they deem it absolutely necessary or using the same tubes for different tests rather than using a different tube of blood for each test. It has also been reported that the global disruption to the supply chain may mean shortages could continue before the supply lines recover. The NHS Supply Chain, has said there was “some improvement in the supply position in September” but that controls on the products "are likely to continue to be applied beyond this until supply stabilises”. Read full story (paywalled). Source: HSJ, 9 August 2021
  18. News Article
    A public inquiry into the infected blood scandal has heard that the government was right to say there was "no conclusive proof" that Aids could be transmitted by blood products in 1983. According to Lord Clarke, the phrase was entirely accurate at the time it was said. However, evidence in documents reveal senior health officials believed HIV could be carried through blood. "Somebody, somewhere, decided that that was the best most accurate line to take. It was repeatedly used by every minister. We kept repeating that because that was the scientific advice we had until it was perfectly clear to the medics that there was in fact sufficient proof... we weren't playing down that possibility. It seems to me... it's a perfectly accurate description of where medical opinion was at that time." Lord Clarke told the inquiry. Read full story. Source: BBC, 28 July 2021
  19. Content Article
    This article discusses a new consultation that has been launched by Robert Francis QC regarding the terms of reference for an independent study into the infected blood scandal. The article covers the suggested scope, the approach and the rationale behind the research and what it won't do, such as run through evidence already heard by the Inquiry.
  20. Content Article
    An article outlining the significance of needlestick injuries - their risks to healthcare workers, their cost, and the importance of prevention.
  21. News Article
    From 1974 to 1987, children from Treloar's College, a boarding school for children with physical disabilities, were offered treatment for haemophilia. However, more than 120 children were given contaminated drug which infected many with HIV and viral hepatitis, with at least 72 having died as a result. Treloar's College had a specialist NHS haemophilia centre on site, however, the blood plasma used to make the drug had been imported from overseas. Only 32 out of the 122 children with haemophilia are still alive today. It is hoped that the public inquiry may shed some light on what happened. Read full story. Source: BBC News, 21 June 2021
  22. News Article
    Oxford writer Wayne Brown describes how he tried donating blood in the middle of the pandemic last year but was turned away due to his same-sex marriage of 14 years. However, since the ban has been lifted, he has already booked his appointment to donate. Wayne Brown discusses how since the ban has been lifted, it may now mean more progress and positive changes are happening for gay men. Read full story. Source: BBC News, 13 June 2021
  23. News Article
    More gay and bisexual men will now be allowed to donate blood after rule change. The new rules which came into effect on World Blood Day mean that men who have sex with other men will now be able to donate blood without being asked about their sexual behaviours. Under the new rules, anyone who has had the same sexual partner for the past three months will be eligible to donate blood, but it will also be based on an individual case by case basis. However, the rules state that anyone who has had anal sex or multiple partners, been exposed to an STI, used pre-exposure prophylaxis (PrEP) or post-exposure prophylaxis (PEP) within the last three months will not be eligible to donate. Read full story Source: Evening Standard, 14 June 2021
  24. Content Article
    Tension pneumothorax can occur following chest trauma, respiratory disease and infection, or during resuscitation requiring invasive or non-invasive ventilation. It is a life-threatening condition resulting from a collapsed lung when air trapped in the pleural cavity compromises cardiopulmonary function. Immediate temporary decompression is required to prevent cardiac arrest. This is commonly done by inserting a needle and cannula, usually used for intravenous access, through the chest wall into the pleural cavity (needle thoracostomy). The needle is withdrawn, and the cannula left in place to allow the trapped air to flow out. New blood control (closed system) intravenous cannulas are increasingly used in the NHS; at least 130 trusts bought a total of three million of them in the last year. They look very similar to both traditional and standard safety cannula (with needle guard or shield) but have an extra integral septum which closes when the needle is withdrawn and stops free flow in or out of the cannula. Flow is only possible once an intravenous line or Luer-lock syringe is attached to the hub, which opens the septum. Blood control (closed system) cannulas help prevent blood spillage, exposure and contamination, when used for their intended intravenous purpose, but they cannot be used to decompress a pneumothorax without additional equipment. The main patient safety risks are: staff may select a blood control (closed system) cannula not realising its limitations for this procedure a blood control (closed system) cannula may wrongly be assumed to be functioning in a patient who is deteriorating rapidly a second needle might be introduced risking very significant damage to the lung as it reinflates.
  25. Content Article
    Sharps injuries (SI) and mucocutaneous exposures (MCE), collectively termed “blood and body fluid exposure” (BBFE), pose a diseases-transmission risk and a psychological stress to health care workers and a responsibility on employers to prevent their occurrence. However, little UK national data is published on their incidence.  The Royal College of Nursing (RCN) present results from a survey of their members.
×
×
  • Create New...